Sökning: "therapeutic drugs"
Visar resultat 1 - 5 av 403 avhandlingar innehållade orden therapeutic drugs.
1. Development of electrochemical sensor and biosensor platforms : detection of therapeutic drugs and heavy metal ions
Sammanfattning : Electrochemical sensors and biosensors combine the sensitivity of electroanalytical methods with the selectivity of a sensor or biosensor surface. The chemical or biochemical component (receptor) in the sensor recognizes an analyte and produces an electrical signal which is proportional to the analyte concentration. LÄS MER
2. Theorizing the therapeutic process in substance use-related dependency treatment
Sammanfattning : The aim of the thesis was to increase knowledge on how to understand the therapeutic process highlighting the importance of the therapeutic relationship as described by therapists and clients in substance use-related dependency treatment. The research questions were related to how the therapeutic process can contribute to a positive outcome considering the therapists’, the clients’ and close co-dependent relatives’ perspectives. LÄS MER
3. Enhancing the therapeutic effect of biological drugs with protein engineering : Focusing on pre-clinical Alzheimer’s disease therapy
Sammanfattning : Aggregation of the amyloid-β peptide (Aβ) is one of the main pathological hallmarks in Alzheimer’s disease (AD). The soluble Aβ aggregates (oligomers and protofibrils) have shown to be the most harmful species. Hence, targeting these aggregates can be of therapeutic potential. LÄS MER
4. Bioanalytical development for application in therapeutic drug monitoring : focus on drugs used in psychiatry
Sammanfattning : Introduction: Since the 1950s and onwards, many new psychoactive drugs have been successfully introduced in clinical practice. A common feature of these drugs is a profound metabolism before clearance from the body. LÄS MER
5. Pharmacokinetics of antidepressant drugs : naturalistic and clinical trials
Sammanfattning : Depression is a major public health problem and it is predicted to be the second leading cause of disease burden by the year 2020. The pharmacological treatment period for major depressive disorder (MDD) is relatively long and sometimes prophylactic over many years. LÄS MER